Skip to main content
NRTSF logo

Nobilis Health Corp. (NRTSF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.000001 $0.00 (0.00%)
P/E Ratio: 0.00| Vol: 225| 52-wk range: $0.000001 – $0.000089

P/E 0.00 means the share price is 0.00 times one year of earnings per share.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Nobilis Health Corp. (NRTSF) trades at $0.000001. Nobilis Health Corp. operates and develops outpatient surgery centers, focusing on delivering innovative surgical services through its medical and marketing services segments. Sector: Healthcare.

Price as of · Last analyzed: Mar 16, 2026
Nobilis Health Corp. operates and develops outpatient surgery centers, focusing on delivering innovative surgical services through its medical and marketing services segments. The company manages ambulatory and acute care facilities, providing patient education and care coordination.

Analyst Coverage for NRTSF: NRTSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • AMS · American Shared Hospital Services · 43 /100
  • CCM · Concord Medical Services Holdings Limited · 26 /100
  • DCGO · DocGo Inc. · 22 /100

See all scored stocks →

Nobilis Health Corp. (NRTSF) Healthcare & Pipeline Overview

CEOPatrick Yoder
Employees700
HeadquartersHouston, CA
IPO Year2011

Nobilis Health Corp., founded in 2007, operates outpatient surgery centers, providing medical and marketing services. With a focus on ambulatory and acute care facilities, the company delivers surgical services, patient education, and care coordination. Trading on the OTC market, Nobilis faces liquidity and disclosure challenges typical of this tier.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for NRTSF?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Nobilis Health Corp. presents a speculative investment opportunity due to its presence in the growing outpatient surgery center market. The company's gross margin of 62.4% indicates potential profitability if operational efficiencies are improved. However, the company's OTC listing and lack of dividend payment introduce significant risk. Key value drivers include expanding the network of outpatient facilities and increasing patient volume through effective marketing strategies. Growth catalysts involve capitalizing on the increasing demand for outpatient surgical procedures and forming strategic partnerships with healthcare providers. Potential risks include regulatory changes, competition from larger healthcare providers, and the challenges associated with operating in the OTC market, including limited liquidity and disclosure requirements. Investors should carefully consider these factors before investing in NRTSF.

Based on FMP financials and quantitative analysis

NRTSF Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Gross margin of 62.4% indicates potential for profitability if operational efficiencies are improved.

  • Operates in the outpatient surgery center market, which is experiencing growth due to cost-effectiveness and patient convenience.
  • Employs 700 individuals, suggesting a significant operational scale.
  • Headquartered in Houston, TX, indicating a regional focus with potential for expansion.
  • Profit margin of 1.3% suggests challenges in converting revenue to profit.

Who Are NRTSF's Competitors?

NRTSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AMS American Shared Hospital Services $1.05 +1.94% $7.01M 43 5-pillar
CCM Concord Medical Services Holdings Limited $3.41 -5.36% $14.8M —
DCGO DocGo Inc. $0.17 -2.22% $17.0M —
BTMD biote Corp. $0.84 -4.65% $27.3M 39 5-pillar
CCEL Cryo-Cell International, Inc. $4.15 -0.48% $33.5M 33 5-pillar
AIRS AirSculpt Technologies, Inc. $0.65 -8.87% $48.4M 33 5-pillar
JYNT The Joint Corp. $6.65 0.00% $91.0M 73 5-pillar
CYH Community Health Systems, Inc. $1.61 -13.49% $227M 52 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NRTSF's Key Strengths?

Established network of outpatient surgery centers.

  • Integrated medical and marketing services.
  • Focus on patient care coordination.
  • Expertise in managing ambulatory and acute care facilities.

What Are NRTSF's Weaknesses?

OTC market listing limits access to capital and investor base.

  • Low profit margin of 1.3% indicates operational inefficiencies.
  • High beta of -328.99 suggests extreme volatility.
  • Dependence on outpatient surgical procedures, making it vulnerable to changes in healthcare regulations.

What Are the Key Risks for NRTSF?

Financial-distress signal — its Altman Z-Score of 0.87 sits in the distress zone (elevated bankruptcy risk).

  • Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
  • Regulatory changes impacting reimbursement rates for outpatient surgical procedures.
  • Increased competition from larger healthcare providers with greater resources.
  • Economic downturn affecting patient demand for elective procedures.
  • Limited liquidity and transparency due to OTC market listing.
  • Potential for medical malpractice claims and litigation.

What Are NRTSF's Competitive Advantages?

  • Established network of outpatient surgery centers.
  • Integrated medical and marketing services.
  • Focus on patient care coordination.
  • Expertise in managing ambulatory and acute care facilities.

What Does NRTSF Do?

Founded on March 16, 2007, and headquartered in Houston, TX, Nobilis Health Corp. is dedicated to the operation and development of outpatient surgery centers. The company owns and manages both ambulatory and acute care facilities, aiming to provide innovative surgical services. Nobilis operates through two primary segments: Medical Services and Marketing Services. The Medical Services segment encompasses the operation of hospitals, outpatient facilities, and a range of related healthcare services. This includes surgical procedures, post-operative care, and other medical treatments. The Marketing Services segment focuses on marketing initiatives, patient education programs, and patient care coordination management. This involves attracting patients to the facilities, educating them about available treatments, and ensuring seamless care transitions. Nobilis aims to differentiate itself through its integrated approach, combining medical expertise with patient-centric marketing and care coordination. The company's business model focuses on providing high-quality surgical services in a cost-effective outpatient setting. As of 2026, Nobilis continues to navigate the competitive healthcare landscape, focusing on operational efficiency and strategic growth initiatives.

What Products and Services Does NRTSF Offer?

  • Operate outpatient surgery centers.
  • Develop new outpatient surgery centers.
  • Manage ambulatory care facilities.
  • Manage acute care facilities.
  • Provide medical services, including surgical procedures.
  • Offer marketing services to attract patients.
  • Provide patient education services.
  • Coordinate patient care management.

How Does NRTSF Make Money?

  • Generate revenue through medical services provided at outpatient surgery centers.
  • Earn revenue from marketing services offered to patients.
  • Focus on ambulatory and acute care facilities to deliver surgical services.
  • Coordinate patient care to ensure seamless transitions and improve outcomes.

What Industry Does NRTSF Operate In?

Nobilis Health Corp. operates within the medical care facilities industry, which is part of the broader healthcare sector. The industry is characterized by increasing demand for outpatient services due to their cost-effectiveness and convenience compared to traditional hospital settings. The market is competitive, with players ranging from large hospital systems to smaller independent surgery centers. Nobilis competes with companies like ACUS, AOBI, APYI, CDXI, and ENCW. The industry is subject to regulatory oversight and reimbursement pressures, impacting profitability and growth. Market trends include the adoption of advanced surgical technologies and the shift towards value-based care models.

Who Are NRTSF's Key Customers?

  • Patients seeking outpatient surgical procedures.
  • Individuals requiring ambulatory care services.
  • Patients needing acute care services.
  • Healthcare providers seeking partnerships for patient care coordination.
Model self-rating on this text: 67% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
F-Score 4/9

Financial Health

Nobilis Health Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.87 places it in the distress zone, a signal of elevated financial risk.

ROE 3%

Key Financial Metrics

Return on equity for Nobilis Health Corp. stands at 2.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.9%, showing how much profit it generates from its asset base. NRTSF trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~21.70x. A current ratio of 2.12 indicates the company holds enough short-term assets to cover its near-term obligations.

Company Profile

Nobilis Health Corp. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Houston, CA. The company is led by CEO Patrick Yoder. NRTSF has traded publicly since 2011.

2/8 beats

Earnings Track Record

Nobilis Health Corp. has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 68.9% below estimates on average.

NRTSF Latest News

No recent news available for NRTSF.

NRTSF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NRTSF.

Price Targets

Wall Street price target analysis for NRTSF.

NRTSF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NRTSF; grades run from A+ (80-100) to F (below 30).

Leadership: Patrick Yoder

CEO

Patrick Yoder is the CEO of Nobilis Health Corp. He is responsible for managing the company's operations and strategic direction. His background includes experience in healthcare management and business development. He oversees a workforce of 700 employees and is focused on expanding the company's network of outpatient surgery centers. Prior to Nobilis, Yoder held leadership positions in various healthcare organizations, focusing on improving patient care and operational efficiency.

Track Record: Under Patrick Yoder's leadership, Nobilis Health Corp. has focused on expanding its network of outpatient surgery centers and enhancing its marketing efforts to attract more patients. Key milestones include implementing advanced surgical technologies and forming strategic partnerships with healthcare providers. Yoder has also focused on improving patient care coordination and reducing readmission rates. However, the company's financial performance has been inconsistent, with challenges in achieving sustained profitability.

NRTSF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Nobilis Health Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial disclosures. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ. This tier is often populated by shell companies, bankrupt entities, or companies with questionable business practices.

  • OTC Tier: OTC Other
Liquidity: Liquidity for NRTSF is likely very limited given its OTC Other listing. Expect wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Low trading volume can result in significant price fluctuations and make it challenging to exit a position quickly. Investors should be prepared for potential delays in executing trades and the possibility of incurring substantial transaction costs due to the illiquidity of the stock.
OTC Risk Factors:
  • Limited liquidity due to low trading volume.
  • Lack of transparency due to limited financial disclosures.
  • Potential for price manipulation and fraud.
  • Higher risk of delisting or going out of business.
  • Limited regulatory oversight compared to listed exchanges.
Due Diligence Checklist:
  • Verify the company's legal standing and business operations.
  • Obtain and review audited financial statements.
  • Assess the company's management team and their track record.
  • Evaluate the company's competitive position and market outlook.
  • Understand the company's capital structure and debt obligations.
  • Determine the reasons for the OTC listing and any past regulatory issues.
  • Consult with a financial advisor and conduct thorough research before investing.
Legitimacy Signals:
  • Operation of outpatient surgery centers indicates real business activity.
  • Employee count of 700 suggests a substantial operational scale.
  • Gross margin of 62.4% suggests potential for profitability.
  • Existence of a CEO (Patrick Yoder) and management team.
  • Company founded in 2007 indicates a history of operations.

Nobilis Health Corp. Healthcare Stock: Key Questions Answered

What do analysts say about NRTSF stock?

Given its OTC listing, limited information is available from traditional analysts. Investors should conduct their own due diligence and consider the risks associated with investing in OTC-listed companies.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available due to OTC market listing.
  • Financial data may not be current or reliable.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

Stock Deep Dives